The newborn blood spot screening in the Netherlands - monitor 2020
report
The Newborn Blood Spot screening programme (NBS) was introduced in the Netherlands in 1974. The programme is coordinated by the Centre for Population Screening (CvB) of the National Institute for Public Health and the Environment (RIVM). The aim of the NBS is the early detection of several serious congenital diseases in newborns. Children with these (rare) diseases benefit from early interventions such as medication or a diet, which can prevent or limit irreparable health damage. During the COVID-19 pandemic, which affected the Netherlands from March 2020, the heel prick screening continued, because most target diseases must be detected as soon as possible after birth to prevent serious health damage. The RIVM-DVP monitored weekly whether there were any particularities related to COVID-19. Also, appointments with care givers were more often online or by telephone.
TNO Identifier
962617
Publisher
TNO
Collation
12 p.
Place of publication
Leiden